Tuesday, April 29, 2025
HomeNews

News

Northern Lights Acquisition Corp. and Safe Harbor Financial Announce Redemption Backstop of Up to $50M in Connection

Northern Lights Acquisition Corp. ("Northern Lights") a special purpose acquisition corporation, and SHF, LLC d/b/a/ Safe Harbor Financial ("Safe Harbor"), a leading financial services...

Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies Summit

Kineta, Inc. ("Kineta" or the "Company"), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology, announced that it presented the...

DTx Leader Sidekick Enters Strategic Collaboration with Lilly to Support Patients with Breast Cancer

International digital therapeutics (DTx) innovator, Sidekick Health (www.sidekickhealth.com), announces an integrated digital therapeutics solution in conjunction with pharmaceutical company Eli Lilly and Company (www.lilly.com)...

Sonivie Receives Ide Approval From FDA for Its Pilot Study to Treat Hypertension

SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound System (TIVUS™) to treat a variety of hypertensive disorders, announced that on May...

Brand Institute Partners on Brand Name Development for European Commission Approved Treatment

Brand Institute is proud to announce having worked with Myovant Sciences in developing the brand name ORGOVYX, for an oral medication used to treat...
0FansLike
0FollowersFollow
spot_img

Hot Topics